Research programme: infectious disease vaccines - iBio

Drug Profile

Research programme: infectious disease vaccines - iBio

Alternative Names: Anthrax vaccine - iBio; Anthrax-plague combination vaccine - iBio; Cancer vaccine - iBio; HPV vaccine - iBio; Influenza A virus H7N9 vaccine - iBio; Malaria vaccine - iBio; Plague vaccine - iBio

Latest Information Update: 28 Nov 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator INB:Biotechnologies
  • Developer iBio Inc
  • Class Anthrax vaccines; Cancer vaccines; Influenza A virus H7N9 vaccines; Papillomavirus vaccines; Parasitic vaccines; Plague vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Bacterial infections; Parasitic infections; Viral infections

Highest Development Phases

  • Preclinical Cancer
  • No development reported Anthrax; Human papillomavirus infections; Influenza A virus H7N9 subtype; Plague

Most Recent Events

  • 18 Oct 2016 iBio has patent protection for iBioModulator™ thermostable immunomodulator protein technology in Canada
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Anthrax in USA (PO)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Human-papillomavirus-infections in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top